Philippa Marrack
Concepts (898)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 228 | 2021 | 1998 | 8.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 64 | 2024 | 336 | 5.030 |
Why?
| | Receptors, Antigen, T-Cell | 114 | 2024 | 719 | 4.890 |
Why?
| | Lymphocyte Activation | 76 | 2020 | 1142 | 4.480 |
Why?
| | Major Histocompatibility Complex | 58 | 2024 | 227 | 4.200 |
Why?
| | CD4-Positive T-Lymphocytes | 42 | 2024 | 1091 | 4.030 |
Why?
| | B-Lymphocytes | 65 | 2018 | 847 | 3.920 |
Why?
| | Thymus Gland | 61 | 2024 | 312 | 3.820 |
Why?
| | Histocompatibility Antigens Class II | 74 | 2021 | 367 | 3.710 |
Why?
| | Adjuvants, Immunologic | 14 | 2017 | 226 | 3.430 |
Why?
| | Autoimmunity | 17 | 2023 | 908 | 3.410 |
Why?
| | CD8-Positive T-Lymphocytes | 25 | 2021 | 903 | 2.870 |
Why?
| | Immunologic Memory | 28 | 2020 | 353 | 2.860 |
Why?
| | Histocompatibility Antigens | 18 | 2019 | 105 | 2.640 |
Why?
| | Mice | 320 | 2024 | 17794 | 2.460 |
Why?
| | Animals | 366 | 2024 | 36951 | 2.250 |
Why?
| | T-Lymphocyte Subsets | 22 | 2018 | 417 | 2.000 |
Why?
| | B-Lymphocyte Subsets | 8 | 2020 | 75 | 1.960 |
Why?
| | Antigens | 40 | 2020 | 357 | 1.920 |
Why?
| | Peptides | 43 | 2021 | 985 | 1.880 |
Why?
| | Alum Compounds | 7 | 2017 | 22 | 1.850 |
Why?
| | Proto-Oncogene Proteins | 13 | 2009 | 648 | 1.800 |
Why?
| | Apoptosis | 18 | 2018 | 2553 | 1.760 |
Why?
| | Mice, Inbred C57BL | 107 | 2024 | 5764 | 1.630 |
Why?
| | Immune Tolerance | 30 | 2021 | 363 | 1.580 |
Why?
| | Toll-Like Receptor 7 | 5 | 2016 | 39 | 1.490 |
Why?
| | T-Box Domain Proteins | 7 | 2020 | 98 | 1.480 |
Why?
| | Dendritic Cells | 11 | 2017 | 483 | 1.460 |
Why?
| | Hybridomas | 73 | 2019 | 237 | 1.440 |
Why?
| | Apoptosis Regulatory Proteins | 11 | 2011 | 188 | 1.410 |
Why?
| | Enterotoxins | 26 | 2009 | 88 | 1.390 |
Why?
| | Mice, Transgenic | 44 | 2024 | 2167 | 1.310 |
Why?
| | Aging | 11 | 2018 | 1865 | 1.280 |
Why?
| | Autoimmune Diseases | 11 | 2021 | 460 | 1.210 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 13 | 2007 | 233 | 1.190 |
Why?
| | Superantigens | 20 | 2019 | 70 | 1.190 |
Why?
| | Membrane Proteins | 12 | 2020 | 1164 | 1.180 |
Why?
| | Autoantigens | 18 | 2021 | 430 | 1.180 |
Why?
| | Antigen-Presenting Cells | 21 | 2015 | 156 | 1.170 |
Why?
| | H-2 Antigens | 38 | 2011 | 115 | 1.140 |
Why?
| | CD11c Antigen | 5 | 2020 | 41 | 1.120 |
Why?
| | Antigen Presentation | 16 | 2017 | 218 | 1.040 |
Why?
| | Antigens, Surface | 24 | 2011 | 154 | 1.010 |
Why?
| | Peptide Fragments | 18 | 2021 | 706 | 0.990 |
Why?
| | Immunity, Cellular | 15 | 2010 | 268 | 0.990 |
Why?
| | Amino Acid Sequence | 65 | 2019 | 2139 | 0.980 |
Why?
| | Spleen | 27 | 2016 | 514 | 0.970 |
Why?
| | Vaccines | 4 | 2017 | 406 | 0.960 |
Why?
| | Herpesviridae Infections | 3 | 2017 | 147 | 0.950 |
Why?
| | Immune System | 7 | 2013 | 177 | 0.950 |
Why?
| | Berylliosis | 5 | 2020 | 186 | 0.940 |
Why?
| | Protein Binding | 31 | 2021 | 2224 | 0.900 |
Why?
| | Autoantibodies | 7 | 2023 | 1497 | 0.900 |
Why?
| | Mammary Tumor Virus, Mouse | 12 | 1995 | 44 | 0.890 |
Why?
| | Interleukin-12 | 2 | 2016 | 121 | 0.890 |
Why?
| | Interleukin-2 | 38 | 2015 | 455 | 0.880 |
Why?
| | Antigens, Viral | 10 | 2001 | 178 | 0.870 |
Why?
| | Epitopes | 46 | 2021 | 479 | 0.870 |
Why?
| | Clone Cells | 18 | 2008 | 265 | 0.870 |
Why?
| | Signal Transduction | 21 | 2018 | 5081 | 0.860 |
Why?
| | Interferon-gamma | 13 | 2016 | 789 | 0.850 |
Why?
| | Molecular Sequence Data | 60 | 2015 | 2900 | 0.840 |
Why?
| | Gene Expression Regulation | 21 | 2015 | 2607 | 0.830 |
Why?
| | Immunoglobulin G | 8 | 2017 | 893 | 0.730 |
Why?
| | Cytokines | 16 | 2020 | 2085 | 0.710 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2020 | 83 | 0.700 |
Why?
| | Cell Differentiation | 31 | 2018 | 1991 | 0.680 |
Why?
| | Cell Survival | 18 | 2009 | 1120 | 0.670 |
Why?
| | Antibody Formation | 19 | 2017 | 298 | 0.660 |
Why?
| | Carrier Proteins | 11 | 2009 | 771 | 0.650 |
Why?
| | Genes, MHC Class II | 19 | 2014 | 74 | 0.640 |
Why?
| | Flow Cytometry | 26 | 2015 | 1178 | 0.640 |
Why?
| | Aluminum | 2 | 2010 | 42 | 0.640 |
Why?
| | Mice, Inbred BALB C | 48 | 2021 | 1272 | 0.640 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 97 | 0.640 |
Why?
| | Lymphocytes | 5 | 2018 | 397 | 0.620 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2019 | 46 | 0.620 |
Why?
| | Alleles | 12 | 2017 | 892 | 0.620 |
Why?
| | Ovalbumin | 23 | 2011 | 183 | 0.620 |
Why?
| | Cell Death | 15 | 2019 | 374 | 0.610 |
Why?
| | Mice, Inbred Strains | 36 | 2000 | 409 | 0.600 |
Why?
| | bcl-2-Associated X Protein | 5 | 2006 | 56 | 0.600 |
Why?
| | Antibodies, Monoclonal | 53 | 2016 | 1430 | 0.590 |
Why?
| | Mice, Knockout | 20 | 2017 | 3018 | 0.590 |
Why?
| | Natural Killer T-Cells | 6 | 2018 | 67 | 0.580 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2020 | 652 | 0.580 |
Why?
| | CD8 Antigens | 10 | 2013 | 75 | 0.580 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2017 | 242 | 0.570 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 9 | 2017 | 853 | 0.570 |
Why?
| | Thymocytes | 3 | 2018 | 36 | 0.560 |
Why?
| | Cells, Cultured | 27 | 2019 | 4193 | 0.560 |
Why?
| | Disease Susceptibility | 1 | 2019 | 347 | 0.550 |
Why?
| | Interleukin-4 | 6 | 2008 | 216 | 0.550 |
Why?
| | Amino Acids | 5 | 2022 | 497 | 0.540 |
Why?
| | Interleukin-15 | 6 | 2013 | 101 | 0.540 |
Why?
| | Herpesviridae | 1 | 2017 | 23 | 0.540 |
Why?
| | Cat Diseases | 1 | 2017 | 21 | 0.540 |
Why?
| | Interleukin-7 | 4 | 2004 | 61 | 0.540 |
Why?
| | Epitopes, T-Lymphocyte | 6 | 2021 | 181 | 0.530 |
Why?
| | Cell Line | 41 | 2021 | 2847 | 0.520 |
Why?
| | Bcl-2-Like Protein 11 | 9 | 2009 | 38 | 0.520 |
Why?
| | Humans | 124 | 2023 | 137782 | 0.510 |
Why?
| | Friend murine leukemia virus | 1 | 2016 | 30 | 0.510 |
Why?
| | Deoxyribonucleases | 1 | 2016 | 24 | 0.510 |
Why?
| | Homeostasis | 5 | 2007 | 621 | 0.500 |
Why?
| | Membrane Glycoproteins | 6 | 2013 | 500 | 0.500 |
Why?
| | Cell Proliferation | 12 | 2020 | 2475 | 0.500 |
Why?
| | Ikaros Transcription Factor | 2 | 2013 | 24 | 0.500 |
Why?
| | Cell Division | 11 | 2008 | 794 | 0.490 |
Why?
| | Complementarity Determining Regions | 6 | 2011 | 51 | 0.490 |
Why?
| | Models, Molecular | 26 | 2018 | 1570 | 0.490 |
Why?
| | Antigens, Neoplasm | 5 | 2021 | 319 | 0.460 |
Why?
| | Influenza A virus | 2 | 2013 | 107 | 0.460 |
Why?
| | Reactive Oxygen Species | 3 | 2003 | 623 | 0.460 |
Why?
| | Antigens, Bacterial | 8 | 2013 | 127 | 0.450 |
Why?
| | Evolution, Molecular | 4 | 2019 | 493 | 0.450 |
Why?
| | Histocompatibility Antigens Class I | 10 | 2013 | 203 | 0.440 |
Why?
| | Histone Demethylases | 3 | 2020 | 32 | 0.440 |
Why?
| | Staphylococcus aureus | 12 | 1999 | 450 | 0.440 |
Why?
| | Immunity, Innate | 6 | 2019 | 828 | 0.440 |
Why?
| | Clonal Deletion | 4 | 2004 | 16 | 0.410 |
Why?
| | Models, Immunological | 8 | 2017 | 100 | 0.410 |
Why?
| | Protein Conformation | 19 | 2018 | 934 | 0.410 |
Why?
| | Nucleoproteins | 1 | 2013 | 27 | 0.410 |
Why?
| | Viral Proteins | 2 | 2009 | 342 | 0.400 |
Why?
| | Hypersensitivity | 2 | 2014 | 257 | 0.400 |
Why?
| | Gammaherpesvirinae | 1 | 2013 | 45 | 0.400 |
Why?
| | T-Lymphocytes, Cytotoxic | 5 | 2012 | 173 | 0.400 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 81 | 0.400 |
Why?
| | Th2 Cells | 3 | 2010 | 176 | 0.400 |
Why?
| | DNA | 10 | 2016 | 1459 | 0.390 |
Why?
| | Lymphocyte Cooperation | 22 | 2006 | 49 | 0.380 |
Why?
| | Base Sequence | 33 | 2015 | 2181 | 0.380 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 110 | 0.380 |
Why?
| | Mutation | 22 | 2022 | 3959 | 0.380 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 37 | 0.380 |
Why?
| | Antibodies | 7 | 2009 | 410 | 0.370 |
Why?
| | bcl-X Protein | 4 | 2006 | 43 | 0.360 |
Why?
| | Staphylococcus | 5 | 1994 | 76 | 0.360 |
Why?
| | Clonal Anergy | 3 | 2006 | 52 | 0.360 |
Why?
| | Binding Sites | 19 | 2021 | 1303 | 0.360 |
Why?
| | Receptors, Chemokine | 2 | 2008 | 47 | 0.360 |
Why?
| | Receptors, Cell Surface | 4 | 2020 | 385 | 0.350 |
Why?
| | Receptors, CXCR5 | 1 | 2011 | 21 | 0.350 |
Why?
| | Lipid A | 1 | 2011 | 29 | 0.350 |
Why?
| | Female | 67 | 2021 | 73465 | 0.350 |
Why?
| | Vaccines, Subunit | 1 | 2011 | 49 | 0.350 |
Why?
| | Th1 Cells | 2 | 2010 | 143 | 0.350 |
Why?
| | Chromosomes, Human, X | 2 | 2015 | 74 | 0.350 |
Why?
| | Mast Cells | 2 | 2009 | 148 | 0.330 |
Why?
| | Inflammation | 5 | 2020 | 2838 | 0.330 |
Why?
| | Germ Cells | 2 | 2016 | 64 | 0.330 |
Why?
| | Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.320 |
Why?
| | Genes | 16 | 1990 | 230 | 0.320 |
Why?
| | Cell Communication | 9 | 2013 | 315 | 0.320 |
Why?
| | Nobel Prize | 1 | 2009 | 4 | 0.320 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 15 | 0.320 |
Why?
| | Gonadal Steroid Hormones | 2 | 2014 | 140 | 0.320 |
Why?
| | Genetics, Medical | 1 | 2009 | 26 | 0.320 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 17 | 1991 | 98 | 0.310 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 94 | 0.310 |
Why?
| | Glycoproteins | 3 | 2011 | 342 | 0.310 |
Why?
| | T-Cell Antigen Receptor Specificity | 3 | 2011 | 50 | 0.310 |
Why?
| | Protein Processing, Post-Translational | 7 | 2018 | 465 | 0.300 |
Why?
| | HLA-DR Antigens | 8 | 2008 | 228 | 0.300 |
Why?
| | Oligonucleotide Array Sequence Analysis | 5 | 2008 | 767 | 0.300 |
Why?
| | Cytotoxicity, Immunologic | 7 | 2009 | 224 | 0.290 |
Why?
| | Receptors, Immunologic | 3 | 2020 | 216 | 0.290 |
Why?
| | Cell Movement | 7 | 2017 | 967 | 0.290 |
Why?
| | Vaccination | 5 | 2010 | 1381 | 0.290 |
Why?
| | Herpesvirus 4, Human | 1 | 2009 | 166 | 0.280 |
Why?
| | Binding, Competitive | 8 | 2003 | 202 | 0.280 |
Why?
| | Allergy and Immunology | 2 | 2006 | 43 | 0.280 |
Why?
| | Transcription Factors | 5 | 2012 | 1719 | 0.280 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 62 | 0.270 |
Why?
| | CD3 Complex | 8 | 2009 | 106 | 0.270 |
Why?
| | Receptors, Interleukin-2 | 4 | 2003 | 66 | 0.270 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 27 | 0.260 |
Why?
| | Bone Marrow Cells | 5 | 2016 | 316 | 0.260 |
Why?
| | Genetic Predisposition to Disease | 4 | 2010 | 2427 | 0.260 |
Why?
| | HLA-DP beta-Chains | 4 | 2014 | 86 | 0.260 |
Why?
| | Inflammation Mediators | 1 | 2009 | 513 | 0.250 |
Why?
| | Diabetes Mellitus, Type 1 | 8 | 2021 | 3717 | 0.250 |
Why?
| | T-Lymphocytes, Helper-Inducer | 10 | 1989 | 137 | 0.250 |
Why?
| | Gene Expression Profiling | 6 | 2018 | 1775 | 0.250 |
Why?
| | RNA, Messenger | 11 | 2022 | 2834 | 0.250 |
Why?
| | Lymph Nodes | 14 | 2015 | 491 | 0.250 |
Why?
| | Histones | 3 | 2018 | 636 | 0.250 |
Why?
| | Transfection | 16 | 2008 | 945 | 0.240 |
Why?
| | Bacterial Toxins | 6 | 1997 | 106 | 0.240 |
Why?
| | Lipopolysaccharides | 10 | 2005 | 886 | 0.240 |
Why?
| | History, 20th Century | 6 | 2016 | 325 | 0.240 |
Why?
| | Antigens, CD1d | 5 | 2013 | 68 | 0.230 |
Why?
| | Cross Reactions | 8 | 2012 | 133 | 0.230 |
Why?
| | Gene Expression | 11 | 2017 | 1502 | 0.230 |
Why?
| | Cytochrome c Group | 5 | 2002 | 43 | 0.230 |
Why?
| | Cell Membrane | 6 | 2004 | 738 | 0.230 |
Why?
| | Heterozygote | 2 | 2024 | 293 | 0.220 |
Why?
| | Protein Folding | 1 | 2006 | 280 | 0.220 |
Why?
| | NF-kappa B | 3 | 2017 | 691 | 0.220 |
Why?
| | Immunoglobulin Variable Region | 11 | 2012 | 80 | 0.220 |
Why?
| | Baculoviridae | 7 | 2015 | 44 | 0.220 |
Why?
| | Beryllium | 3 | 2014 | 153 | 0.220 |
Why?
| | Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.220 |
Why?
| | Insulin | 4 | 2019 | 2411 | 0.220 |
Why?
| | Repressor Proteins | 2 | 2015 | 427 | 0.220 |
Why?
| | Mitochondria | 4 | 2008 | 948 | 0.220 |
Why?
| | Neoplasms, Experimental | 3 | 2021 | 176 | 0.210 |
Why?
| | Lymphokines | 13 | 1984 | 131 | 0.210 |
Why?
| | Cell Separation | 12 | 2008 | 318 | 0.210 |
Why?
| | Interleukin-6 | 3 | 2011 | 778 | 0.210 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 15 | 0.210 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2020 | 29 | 0.200 |
Why?
| | Crystallography, X-Ray | 9 | 2018 | 476 | 0.200 |
Why?
| | Lysosomes | 2 | 2021 | 141 | 0.200 |
Why?
| | Genes, bcl-2 | 1 | 2002 | 21 | 0.200 |
Why?
| | Chromogranin A | 2 | 2015 | 42 | 0.200 |
Why?
| | Chemokine CCL5 | 1 | 2002 | 43 | 0.200 |
Why?
| | Oligopeptides | 2 | 2001 | 271 | 0.200 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2002 | 14 | 0.200 |
Why?
| | beta 2-Microglobulin | 4 | 2010 | 50 | 0.200 |
Why?
| | Clodronic Acid | 1 | 2002 | 17 | 0.190 |
Why?
| | Cloning, Molecular | 13 | 2017 | 534 | 0.190 |
Why?
| | Ubiquitin-Protein Ligases | 3 | 2008 | 175 | 0.190 |
Why?
| | Radiation Chimera | 4 | 2001 | 29 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 5 | 2017 | 388 | 0.190 |
Why?
| | Polymorphism, Genetic | 6 | 2012 | 660 | 0.190 |
Why?
| | Egg Proteins | 1 | 2001 | 17 | 0.190 |
Why?
| | Concanavalin A | 17 | 1990 | 76 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2001 | 363 | 0.190 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2002 | 92 | 0.190 |
Why?
| | Moloney murine leukemia virus | 1 | 2001 | 13 | 0.180 |
Why?
| | Lung Diseases | 2 | 2010 | 767 | 0.180 |
Why?
| | Ligands | 9 | 2022 | 664 | 0.180 |
Why?
| | Mice, Mutant Strains | 7 | 2008 | 298 | 0.180 |
Why?
| | Transcription, Genetic | 7 | 2020 | 1457 | 0.180 |
Why?
| | Interferon-alpha | 4 | 2014 | 198 | 0.180 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2022 | 804 | 0.180 |
Why?
| | Open Reading Frames | 3 | 1992 | 123 | 0.180 |
Why?
| | Protein Structure, Tertiary | 8 | 2021 | 861 | 0.180 |
Why?
| | B7-1 Antigen | 3 | 2004 | 58 | 0.180 |
Why?
| | Transduction, Genetic | 1 | 2001 | 127 | 0.180 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1992 | 113 | 0.180 |
Why?
| | Cathepsins | 1 | 2021 | 24 | 0.180 |
Why?
| | Immunoglobulin Idiotypes | 7 | 1986 | 27 | 0.170 |
Why?
| | HLA-C Antigens | 1 | 2021 | 35 | 0.170 |
Why?
| | Receptors, Fc | 2 | 2020 | 53 | 0.170 |
Why?
| | Chimera | 8 | 2009 | 58 | 0.170 |
Why?
| | Macromolecular Substances | 16 | 2003 | 229 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2006 | 1242 | 0.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 430 | 0.170 |
Why?
| | Immunity, Humoral | 2 | 2022 | 116 | 0.170 |
Why?
| | Self Tolerance | 3 | 2017 | 28 | 0.170 |
Why?
| | Immunity | 3 | 2007 | 143 | 0.170 |
Why?
| | Macrophages | 18 | 2002 | 1549 | 0.170 |
Why?
| | Models, Animal | 1 | 2002 | 384 | 0.170 |
Why?
| | Genetic Vectors | 2 | 2001 | 319 | 0.170 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 10 | 0.170 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 181 | 0.170 |
Why?
| | Hematopoietic Stem Cells | 4 | 2014 | 406 | 0.170 |
Why?
| | RNA Polymerase II | 2 | 2020 | 324 | 0.160 |
Why?
| | Interferon-beta | 3 | 2007 | 92 | 0.160 |
Why?
| | Mice, Inbred NOD | 7 | 2019 | 601 | 0.160 |
Why?
| | Sex Characteristics | 3 | 2015 | 763 | 0.160 |
Why?
| | Transcription Factor AP-1 | 1 | 2000 | 92 | 0.160 |
Why?
| | Receptors, Complement 3d | 1 | 2020 | 141 | 0.160 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2011 | 29 | 0.160 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 267 | 0.160 |
Why?
| | Disease Models, Animal | 6 | 2014 | 4295 | 0.160 |
Why?
| | Genome | 2 | 2000 | 300 | 0.160 |
Why?
| | Kidney | 2 | 2017 | 1475 | 0.160 |
Why?
| | Vaccinia | 1 | 1999 | 20 | 0.150 |
Why?
| | Crosses, Genetic | 7 | 2006 | 137 | 0.150 |
Why?
| | Peptide Library | 4 | 2013 | 92 | 0.150 |
Why?
| | Methyltransferases | 1 | 2020 | 78 | 0.150 |
Why?
| | CD28 Antigens | 2 | 2008 | 53 | 0.150 |
Why?
| | fas Receptor | 4 | 2002 | 95 | 0.150 |
Why?
| | Adaptive Immunity | 2 | 2017 | 165 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2020 | 3569 | 0.150 |
Why?
| | Caspase 1 | 2 | 2009 | 144 | 0.150 |
Why?
| | Lymphocyte Count | 4 | 2010 | 148 | 0.150 |
Why?
| | Trans-Activators | 2 | 2000 | 398 | 0.150 |
Why?
| | Mass Spectrometry | 3 | 2020 | 739 | 0.150 |
Why?
| | Mice, Inbred DBA | 19 | 2002 | 200 | 0.150 |
Why?
| | Male | 30 | 2020 | 67906 | 0.150 |
Why?
| | Nickel | 2 | 2012 | 62 | 0.140 |
Why?
| | Germinal Center | 2 | 2017 | 58 | 0.140 |
Why?
| | Dose-Response Relationship, Immunologic | 11 | 2000 | 82 | 0.140 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2009 | 151 | 0.140 |
Why?
| | Neoplasms | 3 | 2021 | 2673 | 0.140 |
Why?
| | Interferon Type I | 1 | 1999 | 140 | 0.140 |
Why?
| | Complement C3b Inactivator Proteins | 1 | 2017 | 9 | 0.140 |
Why?
| | Adoptive Transfer | 6 | 2015 | 221 | 0.140 |
Why?
| | Minor Histocompatibility Antigens | 2 | 2015 | 48 | 0.140 |
Why?
| | Receptors, Interferon | 2 | 2013 | 52 | 0.140 |
Why?
| | Immunotherapy | 3 | 2021 | 641 | 0.140 |
Why?
| | Antigens, CD | 4 | 2000 | 521 | 0.140 |
Why?
| | Time Factors | 10 | 2013 | 6834 | 0.140 |
Why?
| | CD4 Antigens | 9 | 1998 | 141 | 0.130 |
Why?
| | Retinal Pigment Epithelium | 1 | 2017 | 77 | 0.130 |
Why?
| | Substrate Specificity | 1 | 2017 | 372 | 0.130 |
Why?
| | Receptors, IgE | 1 | 1997 | 45 | 0.130 |
Why?
| | Complement Factor H | 1 | 2017 | 80 | 0.130 |
Why?
| | Cats | 1 | 2017 | 210 | 0.130 |
Why?
| | Blotting, Western | 3 | 2020 | 1227 | 0.130 |
Why?
| | Mice, Inbred C3H | 8 | 1993 | 269 | 0.130 |
Why?
| | Complement Pathway, Alternative | 1 | 2017 | 122 | 0.130 |
Why?
| | Drug Contamination | 1 | 2016 | 53 | 0.130 |
Why?
| | Lupus Nephritis | 4 | 2012 | 63 | 0.120 |
Why?
| | Phenotype | 9 | 2008 | 3196 | 0.120 |
Why?
| | Amino Acid Motifs | 6 | 2019 | 225 | 0.120 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2016 | 99 | 0.120 |
Why?
| | HLA Antigens | 3 | 2013 | 240 | 0.120 |
Why?
| | Immunoconjugates | 1 | 1997 | 114 | 0.120 |
Why?
| | Hematopoiesis | 1 | 1997 | 192 | 0.120 |
Why?
| | Serum Albumin, Bovine | 5 | 2011 | 64 | 0.120 |
Why?
| | Chemokine CCL19 | 1 | 2015 | 6 | 0.120 |
Why?
| | Chemokine CCL21 | 1 | 2015 | 14 | 0.120 |
Why?
| | Immunoglobulin Isotypes | 2 | 2008 | 34 | 0.120 |
Why?
| | Receptors, CCR7 | 1 | 2015 | 32 | 0.120 |
Why?
| | Imidazoles | 1 | 2016 | 238 | 0.120 |
Why?
| | Graft Rejection | 3 | 2015 | 624 | 0.120 |
Why?
| | Down-Regulation | 3 | 2003 | 657 | 0.120 |
Why?
| | Genetic Linkage | 8 | 2002 | 297 | 0.120 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 86 | 0.120 |
Why?
| | Immunization | 8 | 2013 | 411 | 0.120 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 41 | 0.120 |
Why?
| | Sequence Homology, Nucleic Acid | 7 | 1992 | 155 | 0.110 |
Why?
| | Antiviral Agents | 1 | 2021 | 744 | 0.110 |
Why?
| | Skin Transplantation | 1 | 2015 | 85 | 0.110 |
Why?
| | Nicotine | 1 | 2017 | 334 | 0.110 |
Why?
| | Thymoma | 4 | 2012 | 36 | 0.110 |
Why?
| | Immunoglobulin Heavy Chains | 6 | 1988 | 83 | 0.110 |
Why?
| | Macrophages, Alveolar | 1 | 2017 | 391 | 0.110 |
Why?
| | Epithelium | 6 | 1997 | 313 | 0.110 |
Why?
| | Green Fluorescent Proteins | 3 | 2013 | 390 | 0.110 |
Why?
| | Mycobacterium tuberculosis | 1 | 2017 | 314 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 976 | 0.110 |
Why?
| | Granuloma | 1 | 2014 | 92 | 0.110 |
Why?
| | Hybridization, Genetic | 2 | 2014 | 78 | 0.100 |
Why?
| | Molecular Weight | 11 | 2006 | 335 | 0.100 |
Why?
| | Organ Culture Techniques | 6 | 1993 | 156 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 4 | 2004 | 390 | 0.100 |
Why?
| | DNA Mutational Analysis | 2 | 2009 | 399 | 0.100 |
Why?
| | Receptors, Interleukin-7 | 2 | 2006 | 28 | 0.100 |
Why?
| | Chromosome Mapping | 8 | 2002 | 523 | 0.100 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2013 | 382 | 0.100 |
Why?
| | Conserved Sequence | 3 | 2009 | 239 | 0.100 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2013 | 16 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2003 | 2057 | 0.100 |
Why?
| | Lymphocytes, Null | 1 | 2012 | 3 | 0.100 |
Why?
| | HLA-DR4 Antigen | 2 | 2005 | 78 | 0.100 |
Why?
| | Kinetics | 13 | 2021 | 1670 | 0.100 |
Why?
| | Antibodies, Viral | 1 | 2017 | 628 | 0.100 |
Why?
| | Minor Histocompatibility Loci | 2 | 1990 | 4 | 0.100 |
Why?
| | Erythrocytes | 16 | 2002 | 700 | 0.100 |
Why?
| | Diphtheria Toxin | 1 | 2013 | 66 | 0.100 |
Why?
| | Age Factors | 4 | 2017 | 3305 | 0.100 |
Why?
| | Escherichia coli | 4 | 2013 | 815 | 0.100 |
Why?
| | Cell Lineage | 2 | 2013 | 350 | 0.100 |
Why?
| | Mice, Nude | 3 | 2013 | 698 | 0.100 |
Why?
| | Genes, Immunoglobulin | 3 | 1988 | 28 | 0.100 |
Why?
| | Hemocyanins | 8 | 1983 | 62 | 0.100 |
Why?
| | Killer Cells, Natural | 2 | 2007 | 449 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.100 |
Why?
| | DNA Primers | 1 | 2013 | 515 | 0.100 |
Why?
| | Rhadinovirus | 1 | 2012 | 20 | 0.090 |
Why?
| | Galactosylceramides | 2 | 2012 | 25 | 0.090 |
Why?
| | Haplotypes | 4 | 1990 | 494 | 0.090 |
Why?
| | Tumor Virus Infections | 1 | 2012 | 49 | 0.090 |
Why?
| | Burkitt Lymphoma | 1 | 2012 | 60 | 0.090 |
Why?
| | Immunophenotyping | 3 | 2004 | 318 | 0.090 |
Why?
| | Mice, Inbred CBA | 8 | 1991 | 54 | 0.090 |
Why?
| | Virus Diseases | 2 | 1992 | 212 | 0.090 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 73 | 0.090 |
Why?
| | Communicable Diseases | 1 | 1994 | 159 | 0.090 |
Why?
| | Ubiquitination | 2 | 2008 | 102 | 0.090 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2007 | 69 | 0.090 |
Why?
| | Nucleocapsid Proteins | 1 | 2011 | 23 | 0.090 |
Why?
| | Viral Core Proteins | 1 | 2011 | 18 | 0.090 |
Why?
| | Resting Phase, Cell Cycle | 1 | 2011 | 15 | 0.090 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 2011 | 16 | 0.090 |
Why?
| | Surface Plasmon Resonance | 3 | 2021 | 87 | 0.090 |
Why?
| | Salts | 1 | 2010 | 37 | 0.090 |
Why?
| | Bone Marrow | 2 | 2009 | 286 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 7 | 2011 | 345 | 0.080 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 67 | 0.080 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.080 |
Why?
| | Structure-Activity Relationship | 8 | 2006 | 570 | 0.080 |
Why?
| | Antibody Specificity | 7 | 1997 | 189 | 0.080 |
Why?
| | HLA-DP Antigens | 1 | 2010 | 33 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 860 | 0.080 |
Why?
| | Immunoprecipitation | 2 | 2008 | 155 | 0.080 |
Why?
| | Species Specificity | 10 | 2006 | 585 | 0.080 |
Why?
| | Cattle | 2 | 2011 | 985 | 0.080 |
Why?
| | Recombinant Proteins | 7 | 2005 | 1356 | 0.080 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 3415 | 0.080 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 6 | 1999 | 30 | 0.080 |
Why?
| | Fibrin | 1 | 2010 | 83 | 0.080 |
Why?
| | Antigen-Antibody Reactions | 6 | 2021 | 55 | 0.080 |
Why?
| | France | 1 | 2009 | 33 | 0.080 |
Why?
| | Molecular Docking Simulation | 2 | 2021 | 114 | 0.080 |
Why?
| | Thrombin | 1 | 2010 | 152 | 0.080 |
Why?
| | Fibrinogen | 1 | 2010 | 170 | 0.080 |
Why?
| | Injections, Intraperitoneal | 1 | 2009 | 114 | 0.080 |
Why?
| | Aluminum Compounds | 1 | 2009 | 5 | 0.080 |
Why?
| | Retroviridae | 2 | 2013 | 97 | 0.080 |
Why?
| | Antioxidants | 2 | 2003 | 585 | 0.080 |
Why?
| | Antibodies, Neutralizing | 2 | 2022 | 286 | 0.080 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2009 | 21 | 0.080 |
Why?
| | Phosphorylation | 4 | 2020 | 1759 | 0.080 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 20 | 0.080 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2011 | 249 | 0.080 |
Why?
| | CD4-CD8 Ratio | 2 | 2002 | 22 | 0.080 |
Why?
| | Antibody Affinity | 3 | 2005 | 60 | 0.070 |
Why?
| | Integrin alpha4 | 1 | 2008 | 7 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2008 | 12 | 0.070 |
Why?
| | Cell Adhesion Molecules | 1 | 1990 | 181 | 0.070 |
Why?
| | Adsorption | 1 | 2009 | 149 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 3 | 2004 | 385 | 0.070 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2008 | 19 | 0.070 |
Why?
| | History, 21st Century | 1 | 2009 | 213 | 0.070 |
Why?
| | Genes, Switch | 1 | 1988 | 6 | 0.070 |
Why?
| | Chondroitin | 1 | 1988 | 5 | 0.070 |
Why?
| | Cytoskeletal Proteins | 1 | 2009 | 158 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7637 | 0.070 |
Why?
| | Antigens, Helminth | 1 | 2008 | 12 | 0.070 |
Why?
| | Genes, Regulator | 1 | 1988 | 37 | 0.070 |
Why?
| | Schistosoma mansoni | 1 | 2008 | 37 | 0.070 |
Why?
| | Chondroitin Sulfates | 1 | 1988 | 32 | 0.070 |
Why?
| | Histocompatibility Antigen H-2D | 3 | 2010 | 21 | 0.070 |
Why?
| | Biomarkers | 1 | 2019 | 4154 | 0.070 |
Why?
| | Liposomes | 3 | 2005 | 224 | 0.070 |
Why?
| | Methylation | 3 | 2018 | 230 | 0.070 |
Why?
| | Influenza Vaccines | 1 | 2013 | 539 | 0.070 |
Why?
| | Protein Domains | 2 | 2020 | 289 | 0.070 |
Why?
| | Polymerase Chain Reaction | 6 | 1997 | 1062 | 0.070 |
Why?
| | Mice, Inbred AKR | 10 | 1989 | 35 | 0.070 |
Why?
| | Transplantation Chimera | 3 | 2014 | 54 | 0.070 |
Why?
| | Biosensing Techniques | 1 | 2009 | 129 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 5 | 2002 | 665 | 0.070 |
Why?
| | Hybrid Cells | 4 | 1997 | 49 | 0.070 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2007 | 34 | 0.070 |
Why?
| | Pancreas | 2 | 2021 | 329 | 0.070 |
Why?
| | Fluoresceins | 2 | 2004 | 47 | 0.070 |
Why?
| | Infection Control | 1 | 2009 | 167 | 0.070 |
Why?
| | Aged | 3 | 2020 | 24001 | 0.070 |
Why?
| | Moths | 3 | 1997 | 45 | 0.070 |
Why?
| | Immunoglobulin Fab Fragments | 2 | 2006 | 59 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2011 | 422 | 0.070 |
Why?
| | In Vitro Techniques | 8 | 2000 | 1092 | 0.070 |
Why?
| | Arthritis, Rheumatoid | 3 | 2005 | 1168 | 0.060 |
Why?
| | Early Growth Response Protein 2 | 2 | 2018 | 10 | 0.060 |
Why?
| | Poly I-C | 1 | 2006 | 63 | 0.060 |
Why?
| | Health | 1 | 2007 | 84 | 0.060 |
Why?
| | Chemokines | 1 | 2007 | 228 | 0.060 |
Why?
| | B-Cell Activating Factor | 1 | 2006 | 21 | 0.060 |
Why?
| | Hyaluronan Receptors | 3 | 2003 | 102 | 0.060 |
Why?
| | Tissue Distribution | 3 | 1993 | 332 | 0.060 |
Why?
| | Chemotaxis, Leukocyte | 2 | 2003 | 136 | 0.060 |
Why?
| | Arginine | 2 | 2018 | 271 | 0.060 |
Why?
| | Leukopoiesis | 1 | 2006 | 11 | 0.060 |
Why?
| | Transgenes | 2 | 1997 | 180 | 0.060 |
Why?
| | Spodoptera | 2 | 2021 | 40 | 0.060 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 111 | 0.060 |
Why?
| | Caspases | 2 | 2014 | 247 | 0.060 |
Why?
| | Promoter Regions, Genetic | 4 | 2020 | 1251 | 0.060 |
Why?
| | Cell Fusion | 4 | 1989 | 51 | 0.060 |
Why?
| | HLA-D Antigens | 2 | 1998 | 34 | 0.060 |
Why?
| | Protein Structure, Secondary | 4 | 2012 | 374 | 0.060 |
Why?
| | Enzyme Activation | 3 | 2008 | 810 | 0.060 |
Why?
| | Insulin-Secreting Cells | 1 | 2010 | 377 | 0.060 |
Why?
| | Prostaglandins E | 1 | 1985 | 47 | 0.060 |
Why?
| | Sheep | 11 | 1983 | 856 | 0.060 |
Why?
| | Leukemia P388 | 2 | 1984 | 7 | 0.060 |
Why?
| | Succinimides | 1 | 2004 | 19 | 0.060 |
Why?
| | Lymphocyte Depletion | 4 | 2001 | 135 | 0.060 |
Why?
| | Whole-Body Irradiation | 2 | 2013 | 78 | 0.060 |
Why?
| | Proteolysis | 2 | 2018 | 177 | 0.060 |
Why?
| | Models, Biological | 3 | 2001 | 1783 | 0.060 |
Why?
| | Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.060 |
Why?
| | MAP Kinase Kinase Kinases | 2 | 2008 | 73 | 0.060 |
Why?
| | Phosphatidylserines | 1 | 2005 | 91 | 0.060 |
Why?
| | Vaccinia virus | 2 | 2001 | 43 | 0.060 |
Why?
| | Plasmids | 4 | 2001 | 363 | 0.060 |
Why?
| | Tumor Cells, Cultured | 4 | 2001 | 955 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2004 | 272 | 0.050 |
Why?
| | B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 2 | 0.050 |
Why?
| | Phosphoserine | 1 | 2004 | 34 | 0.050 |
Why?
| | Antigens, Differentiation | 2 | 1997 | 83 | 0.050 |
Why?
| | Leukemia, Experimental | 1 | 1983 | 27 | 0.050 |
Why?
| | Receptors, Leukotriene B4 | 1 | 2003 | 7 | 0.050 |
Why?
| | Fibroblasts | 3 | 2017 | 996 | 0.050 |
Why?
| | Young Adult | 1 | 2020 | 13240 | 0.050 |
Why?
| | Sex Factors | 1 | 2010 | 2077 | 0.050 |
Why?
| | Leukotriene B4 | 1 | 2003 | 42 | 0.050 |
Why?
| | Fetus | 4 | 2014 | 806 | 0.050 |
Why?
| | Lung | 4 | 2014 | 4060 | 0.050 |
Why?
| | Catalase | 1 | 2003 | 130 | 0.050 |
Why?
| | Luminescent Proteins | 2 | 2001 | 179 | 0.050 |
Why?
| | Chromosome Deletion | 4 | 1991 | 115 | 0.050 |
Why?
| | Bone Marrow Transplantation | 3 | 2014 | 286 | 0.050 |
Why?
| | Antibody-Producing Cells | 7 | 1983 | 30 | 0.050 |
Why?
| | Fas Ligand Protein | 1 | 2003 | 60 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2004 | 148 | 0.050 |
Why?
| | Incidence | 1 | 2010 | 2804 | 0.050 |
Why?
| | RNA | 3 | 2003 | 921 | 0.050 |
Why?
| | Selection, Genetic | 2 | 2019 | 274 | 0.050 |
Why?
| | Solubility | 4 | 1998 | 245 | 0.050 |
Why?
| | Fluorescent Dyes | 2 | 2001 | 321 | 0.050 |
Why?
| | Binding Sites, Antibody | 5 | 1991 | 42 | 0.050 |
Why?
| | Interleukin-1 | 5 | 1997 | 965 | 0.050 |
Why?
| | Antigens, Ly | 4 | 1988 | 44 | 0.050 |
Why?
| | Protein Biosynthesis | 3 | 1992 | 433 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 126 | 0.050 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2002 | 184 | 0.050 |
Why?
| | Sequence Alignment | 2 | 2008 | 343 | 0.050 |
Why?
| | Mesencephalon | 1 | 2002 | 66 | 0.050 |
Why?
| | Synovial Fluid | 2 | 2000 | 68 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2002 | 164 | 0.050 |
Why?
| | Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| | Chronic Disease | 3 | 2013 | 1794 | 0.040 |
Why?
| | Crystallization | 2 | 2015 | 143 | 0.040 |
Why?
| | Interphase | 2 | 2000 | 32 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2002 | 194 | 0.040 |
Why?
| | Sex Chromosome Aberrations | 1 | 1981 | 65 | 0.040 |
Why?
| | Hemolytic Plaque Technique | 10 | 1983 | 29 | 0.040 |
Why?
| | Calcium | 6 | 2004 | 1200 | 0.040 |
Why?
| | Growth Inhibitors | 1 | 2001 | 43 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 1 | 2005 | 557 | 0.040 |
Why?
| | Borrelia burgdorferi Group | 1 | 2000 | 9 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2001 | 89 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2001 | 114 | 0.040 |
Why?
| | Up-Regulation | 1 | 2003 | 843 | 0.040 |
Why?
| | Receptors, Virus | 1 | 2021 | 83 | 0.040 |
Why?
| | Temperature | 1 | 2003 | 679 | 0.040 |
Why?
| | Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 2 | 1999 | 190 | 0.040 |
Why?
| | Phorbol Esters | 1 | 2000 | 14 | 0.040 |
Why?
| | Antibody Diversity | 3 | 1989 | 16 | 0.040 |
Why?
| | Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 12 | 0.040 |
Why?
| | Lymphocyte Culture Test, Mixed | 3 | 1990 | 50 | 0.040 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2000 | 60 | 0.040 |
Why?
| | Phagocytosis | 1 | 2002 | 382 | 0.040 |
Why?
| | Expressed Sequence Tags | 1 | 2000 | 42 | 0.040 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 21 | 0.040 |
Why?
| | Haploidy | 1 | 1980 | 26 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2000 | 43 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2000 | 134 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 150 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2000 | 72 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 2000 | 106 | 0.040 |
Why?
| | Immunosuppressive Agents | 1 | 2005 | 894 | 0.040 |
Why?
| | Cancer Vaccines | 1 | 2021 | 172 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2000 | 145 | 0.040 |
Why?
| | Lymphocyte Transfusion | 1 | 1999 | 21 | 0.040 |
Why?
| | Leukemia L1210 | 1 | 1999 | 8 | 0.040 |
Why?
| | Middle Aged | 2 | 2020 | 33554 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 118 | 0.040 |
Why?
| | Lipoproteins | 1 | 2000 | 168 | 0.040 |
Why?
| | Haptens | 3 | 1988 | 22 | 0.040 |
Why?
| | Rats | 5 | 2002 | 5648 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1502 | 0.040 |
Why?
| | Lymphopenia | 1 | 1999 | 62 | 0.040 |
Why?
| | Free Radical Scavengers | 1 | 1999 | 88 | 0.040 |
Why?
| | Chickens | 5 | 1994 | 191 | 0.040 |
Why?
| | Recombination, Genetic | 4 | 1988 | 204 | 0.040 |
Why?
| | Peer Review, Research | 1 | 1999 | 43 | 0.040 |
Why?
| | Manganese | 1 | 1999 | 62 | 0.040 |
Why?
| | Cholic Acids | 1 | 1998 | 18 | 0.040 |
Why?
| | HIV Envelope Protein gp120 | 1 | 1999 | 60 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 1999 | 128 | 0.040 |
Why?
| | Adult | 3 | 2020 | 38023 | 0.040 |
Why?
| | Detergents | 1 | 1998 | 44 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 231 | 0.040 |
Why?
| | Metalloporphyrins | 1 | 1999 | 103 | 0.040 |
Why?
| | Cell Cycle | 2 | 2020 | 601 | 0.040 |
Why?
| | Trinitrobenzenes | 5 | 1982 | 14 | 0.040 |
Why?
| | Coculture Techniques | 2 | 2013 | 239 | 0.040 |
Why?
| | Membrane Potentials | 1 | 1999 | 284 | 0.040 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2005 | 143 | 0.040 |
Why?
| | Nucleosomes | 1 | 2020 | 155 | 0.040 |
Why?
| | Behavior, Animal | 1 | 2002 | 501 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2000 | 206 | 0.040 |
Why?
| | Neutrophils | 1 | 2004 | 1238 | 0.040 |
Why?
| | Crystallography | 2 | 2007 | 28 | 0.040 |
Why?
| | Mice, Inbred A | 6 | 1984 | 49 | 0.040 |
Why?
| | NFATC Transcription Factors | 1 | 2018 | 95 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 101 | 0.040 |
Why?
| | Hot Temperature | 2 | 2000 | 391 | 0.030 |
Why?
| | Autophagosomes | 1 | 2017 | 19 | 0.030 |
Why?
| | Lymphoma | 5 | 1985 | 212 | 0.030 |
Why?
| | Recovery of Function | 1 | 2002 | 653 | 0.030 |
Why?
| | Nicotinic Antagonists | 1 | 2017 | 34 | 0.030 |
Why?
| | Endocytosis | 1 | 1998 | 172 | 0.030 |
Why?
| | STAT6 Transcription Factor | 1 | 1997 | 27 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 364 | 0.030 |
Why?
| | Dinoprostone | 2 | 1991 | 191 | 0.030 |
Why?
| | Neoplasm Transplantation | 2 | 2012 | 257 | 0.030 |
Why?
| | Mutagenesis | 2 | 2013 | 179 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 1999 | 320 | 0.030 |
Why?
| | Oligonucleotides | 2 | 2004 | 148 | 0.030 |
Why?
| | Receptors, Complement | 1 | 2017 | 122 | 0.030 |
Why?
| | Columbidae | 2 | 1994 | 31 | 0.030 |
Why?
| | Abatacept | 1 | 1997 | 56 | 0.030 |
Why?
| | Interleukins | 1 | 1999 | 250 | 0.030 |
Why?
| | Societies, Medical | 1 | 2001 | 820 | 0.030 |
Why?
| | Phylogeny | 1 | 2021 | 904 | 0.030 |
Why?
| | Immunomodulation | 1 | 2017 | 98 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 171 | 0.030 |
Why?
| | CTLA-4 Antigen | 1 | 1997 | 99 | 0.030 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 68 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 1997 | 307 | 0.030 |
Why?
| | Respiratory Hypersensitivity | 1 | 1997 | 69 | 0.030 |
Why?
| | Gene Deletion | 2 | 2009 | 391 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 239 | 0.030 |
Why?
| | Germ-Line Mutation | 2 | 2009 | 172 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1986 | 67 | 0.030 |
Why?
| | Hemolysis | 1 | 2017 | 206 | 0.030 |
Why?
| | Molecular Conformation | 2 | 2009 | 145 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 1997 | 97 | 0.030 |
Why?
| | Sequence Homology | 1 | 1995 | 40 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2002 | 498 | 0.030 |
Why?
| | Nitrophenols | 4 | 2004 | 34 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2003 | 560 | 0.030 |
Why?
| | Molecular Structure | 2 | 2003 | 489 | 0.030 |
Why?
| | Epitope Mapping | 2 | 2011 | 62 | 0.030 |
Why?
| | Immunoglobulins | 2 | 1987 | 171 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 2015 | 126 | 0.030 |
Why?
| | gamma-Globulins | 4 | 1983 | 18 | 0.030 |
Why?
| | Antilymphocyte Serum | 8 | 1981 | 66 | 0.030 |
Why?
| | Receptors, Nicotinic | 1 | 2017 | 334 | 0.030 |
Why?
| | Insecta | 2 | 2006 | 67 | 0.030 |
Why?
| | Autophagy | 1 | 2017 | 284 | 0.030 |
Why?
| | Immunoglobulin E | 2 | 1997 | 345 | 0.030 |
Why?
| | Protein Transport | 2 | 2008 | 445 | 0.030 |
Why?
| | V(D)J Recombination | 1 | 2014 | 8 | 0.030 |
Why?
| | Peptide Biosynthesis | 1 | 1994 | 13 | 0.030 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 162 | 0.030 |
Why?
| | Enzyme-Linked Immunospot Assay | 1 | 2014 | 36 | 0.030 |
Why?
| | Databases, Factual | 1 | 2000 | 1357 | 0.030 |
Why?
| | Cell Adhesion | 3 | 1999 | 466 | 0.030 |
Why?
| | Gene Dosage | 1 | 2014 | 140 | 0.030 |
Why?
| | Horses | 4 | 1981 | 111 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 411 | 0.030 |
Why?
| | Cysteine | 2 | 2010 | 204 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2015 | 416 | 0.030 |
Why?
| | Disulfides | 2 | 1984 | 107 | 0.030 |
Why?
| | Transferrin | 1 | 1993 | 47 | 0.030 |
Why?
| | Transplantation Immunology | 1 | 1993 | 34 | 0.030 |
Why?
| | Cell Transplantation | 1 | 1993 | 37 | 0.030 |
Why?
| | Multigene Family | 2 | 1991 | 198 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2011 | 375 | 0.030 |
Why?
| | Trypsin | 4 | 2006 | 77 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 191 | 0.030 |
Why?
| | Hydrogen Bonding | 2 | 2008 | 163 | 0.030 |
Why?
| | Sodium | 1 | 2014 | 217 | 0.030 |
Why?
| | Viral Envelope Proteins | 1 | 1994 | 84 | 0.030 |
Why?
| | Endopeptidase K | 1 | 2013 | 17 | 0.030 |
Why?
| | Growth Substances | 2 | 1983 | 147 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1993 | 73 | 0.030 |
Why?
| | Fetal Tissue Transplantation | 1 | 1992 | 35 | 0.030 |
Why?
| | HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.020 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2013 | 27 | 0.020 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 26 | 0.020 |
Why?
| | United States | 3 | 2015 | 14870 | 0.020 |
Why?
| | Hepatocytes | 1 | 2014 | 220 | 0.020 |
Why?
| | Vomiting | 1 | 1993 | 130 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 660 | 0.020 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2012 | 38 | 0.020 |
Why?
| | Embryonic and Fetal Development | 1 | 1992 | 97 | 0.020 |
Why?
| | Perissodactyla | 4 | 1981 | 12 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2012 | 126 | 0.020 |
Why?
| | Disease | 1 | 1993 | 98 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 1997 | 623 | 0.020 |
Why?
| | Ionomycin | 1 | 1991 | 23 | 0.020 |
Why?
| | Immunoassay | 2 | 1989 | 115 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1991 | 150 | 0.020 |
Why?
| | DNA, Recombinant | 3 | 2005 | 47 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 1 | 1992 | 112 | 0.020 |
Why?
| | DNA Methylation | 1 | 1996 | 643 | 0.020 |
Why?
| | Receptors, Natural Killer Cell | 1 | 2011 | 16 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1316 | 0.020 |
Why?
| | Genotype | 1 | 1996 | 1917 | 0.020 |
Why?
| | Mice, Inbred NZB | 2 | 2007 | 16 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 309 | 0.020 |
Why?
| | Glycosylation | 4 | 1994 | 151 | 0.020 |
Why?
| | Blotting, Northern | 1 | 1991 | 201 | 0.020 |
Why?
| | Cellular Senescence | 1 | 1993 | 189 | 0.020 |
Why?
| | Mutant Chimeric Proteins | 1 | 2010 | 5 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 1992 | 337 | 0.020 |
Why?
| | Receptors, Leukocyte-Adhesion | 1 | 1990 | 5 | 0.020 |
Why?
| | Depression, Chemical | 1 | 1990 | 23 | 0.020 |
Why?
| | Lysine | 1 | 2012 | 294 | 0.020 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 8 | 0.020 |
Why?
| | Milk | 1 | 1991 | 124 | 0.020 |
Why?
| | Pregnancy | 2 | 2014 | 6771 | 0.020 |
Why?
| | Oligonucleotide Probes | 1 | 1990 | 51 | 0.020 |
Why?
| | Epoprostenol | 1 | 1991 | 136 | 0.020 |
Why?
| | RNA Splicing | 1 | 1991 | 269 | 0.020 |
Why?
| | Immunotherapy, Adoptive | 1 | 1993 | 332 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 55 | 0.020 |
Why?
| | Amidohydrolases | 1 | 1990 | 31 | 0.020 |
Why?
| | Restriction Mapping | 3 | 1998 | 77 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2014 | 408 | 0.020 |
Why?
| | Histidine | 2 | 2003 | 64 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 163 | 0.020 |
Why?
| | Smoking | 1 | 2017 | 1627 | 0.020 |
Why?
| | Precipitin Tests | 2 | 1991 | 100 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2013 | 518 | 0.020 |
Why?
| | Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| | Leukemia, Lymphoid | 2 | 2006 | 27 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 506 | 0.020 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 15 | 0.020 |
Why?
| | Homozygote | 1 | 1989 | 203 | 0.020 |
Why?
| | Gestational Age | 1 | 1992 | 910 | 0.020 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 38 | 0.020 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2008 | 49 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 32 | 0.020 |
Why?
| | Eosinophils | 2 | 2004 | 334 | 0.020 |
Why?
| | Animals, Newborn | 2 | 1988 | 844 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2008 | 144 | 0.020 |
Why?
| | Caspase Inhibitors | 1 | 2008 | 81 | 0.020 |
Why?
| | Immune Sera | 2 | 2005 | 88 | 0.020 |
Why?
| | Microspheres | 1 | 1988 | 137 | 0.020 |
Why?
| | Immunoblotting | 1 | 2008 | 308 | 0.020 |
Why?
| | Nitrobenzenes | 3 | 1976 | 13 | 0.020 |
Why?
| | Shock, Septic | 1 | 1990 | 219 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2010 | 246 | 0.020 |
Why?
| | Mice, Congenic | 1 | 2007 | 22 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 128 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 2008 | 107 | 0.020 |
Why?
| | Leukocyte Count | 1 | 1988 | 331 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2002 | 10837 | 0.020 |
Why?
| | Antigens, CD1 | 1 | 2007 | 58 | 0.020 |
Why?
| | Biological Transport | 2 | 1999 | 418 | 0.020 |
Why?
| | Epithelial Cells | 1 | 1993 | 1096 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2006 | 55 | 0.020 |
Why?
| | Cytoplasm | 2 | 2004 | 274 | 0.020 |
Why?
| | Immunoglobulin gamma-Chains | 1 | 1986 | 2 | 0.020 |
Why?
| | Antibodies, Antinuclear | 1 | 2006 | 71 | 0.020 |
Why?
| | Antigens, T-Independent | 2 | 1983 | 4 | 0.020 |
Why?
| | Weight Loss | 1 | 1992 | 788 | 0.020 |
Why?
| | Proteinuria | 1 | 2006 | 97 | 0.020 |
Why?
| | Glass | 1 | 1986 | 45 | 0.020 |
Why?
| | Proteins | 2 | 1982 | 1009 | 0.020 |
Why?
| | Kidney Glomerulus | 1 | 2006 | 119 | 0.020 |
Why?
| | Liver | 2 | 1992 | 1943 | 0.020 |
Why?
| | Body Weight | 1 | 1990 | 985 | 0.010 |
Why?
| | Mast-Cell Sarcoma | 1 | 1985 | 6 | 0.010 |
Why?
| | Transformation, Genetic | 1 | 1985 | 16 | 0.010 |
Why?
| | Cricetinae | 3 | 1994 | 289 | 0.010 |
Why?
| | Liver Transplantation | 1 | 1992 | 871 | 0.010 |
Why?
| | Stereoisomerism | 1 | 2005 | 96 | 0.010 |
Why?
| | Prevalence | 1 | 2012 | 2734 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 2005 | 157 | 0.010 |
Why?
| | Freund's Adjuvant | 1 | 2004 | 18 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1984 | 362 | 0.010 |
Why?
| | Rosette Formation | 2 | 1980 | 16 | 0.010 |
Why?
| | Isoelectric Point | 1 | 1984 | 25 | 0.010 |
Why?
| | Genetic Markers | 1 | 1985 | 344 | 0.010 |
Why?
| | Isoelectric Focusing | 1 | 1983 | 34 | 0.010 |
Why?
| | Gene Library | 1 | 2004 | 118 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2004 | 139 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 152 | 0.010 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 196 | 0.010 |
Why?
| | Receptors, CCR5 | 1 | 2003 | 56 | 0.010 |
Why?
| | Chemical Precipitation | 1 | 1983 | 37 | 0.010 |
Why?
| | Karyotyping | 1 | 1983 | 104 | 0.010 |
Why?
| | Birds | 1 | 1983 | 93 | 0.010 |
Why?
| | Phosphates | 1 | 2004 | 182 | 0.010 |
Why?
| | Rabbits | 3 | 1984 | 794 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2005 | 338 | 0.010 |
Why?
| | Lod Score | 1 | 2002 | 67 | 0.010 |
Why?
| | Oxidopamine | 1 | 2002 | 17 | 0.010 |
Why?
| | Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| | Sympatholytics | 1 | 2002 | 15 | 0.010 |
Why?
| | Transplantation, Heterotopic | 1 | 2002 | 18 | 0.010 |
Why?
| | DNA, Viral | 1 | 2004 | 364 | 0.010 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2002 | 72 | 0.010 |
Why?
| | X Chromosome | 1 | 1981 | 53 | 0.010 |
Why?
| | Interleukin-5 | 1 | 1982 | 44 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2004 | 437 | 0.010 |
Why?
| | DNA Restriction Enzymes | 3 | 1986 | 52 | 0.010 |
Why?
| | Immunoglobulin Constant Regions | 3 | 1986 | 7 | 0.010 |
Why?
| | Thymectomy | 3 | 1975 | 15 | 0.010 |
Why?
| | Methamphetamine | 1 | 2002 | 63 | 0.010 |
Why?
| | Organ Specificity | 1 | 2001 | 305 | 0.010 |
Why?
| | Chromatography, Gel | 2 | 1983 | 127 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 269 | 0.010 |
Why?
| | Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 812 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2005 | 617 | 0.010 |
Why?
| | Biopolymers | 1 | 2000 | 31 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 2000 | 63 | 0.010 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2000 | 58 | 0.010 |
Why?
| | Corpus Striatum | 1 | 2002 | 168 | 0.010 |
Why?
| | HLA-DRB1 Chains | 1 | 2000 | 113 | 0.010 |
Why?
| | MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| | Lyme Disease | 1 | 2000 | 60 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1999 | 96 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1980 | 151 | 0.010 |
Why?
| | Androstadienes | 1 | 1999 | 107 | 0.010 |
Why?
| | Immunization, Secondary | 1 | 1999 | 87 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 152 | 0.010 |
Why?
| | Half-Life | 2 | 1977 | 164 | 0.010 |
Why?
| | Computer Simulation | 1 | 2003 | 982 | 0.010 |
Why?
| | Public Policy | 1 | 1999 | 85 | 0.010 |
Why?
| | Dopamine | 1 | 2002 | 304 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 185 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 283 | 0.010 |
Why?
| | Cartilage | 1 | 2000 | 188 | 0.010 |
Why?
| | Asparagine | 1 | 1998 | 31 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 2 | 1975 | 70 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 313 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 1999 | 402 | 0.010 |
Why?
| | Codon | 1 | 1998 | 89 | 0.010 |
Why?
| | Histocompatibility | 1 | 1977 | 28 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1999 | 366 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1738 | 0.010 |
Why?
| | Collagen | 1 | 2000 | 452 | 0.010 |
Why?
| | Dimerization | 1 | 1997 | 199 | 0.010 |
Why?
| | Warfarin | 1 | 1978 | 154 | 0.010 |
Why?
| | Antigen-Antibody Complex | 2 | 1987 | 90 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2002 | 2487 | 0.010 |
Why?
| | Research | 1 | 1999 | 451 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 840 | 0.010 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 1996 | 73 | 0.010 |
Why?
| | Radiation Effects | 1 | 1975 | 7 | 0.010 |
Why?
| | Absorption | 1 | 1975 | 63 | 0.010 |
Why?
| | Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| | Surface Properties | 1 | 1976 | 413 | 0.010 |
Why?
| | Trachea | 1 | 1997 | 237 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 1994 | 77 | 0.010 |
Why?
| | Endopeptidases | 1 | 1994 | 90 | 0.010 |
Why?
| | Hemoglobins | 1 | 1996 | 353 | 0.010 |
Why?
| | Golgi Apparatus | 1 | 1994 | 100 | 0.010 |
Why?
| | Umbilical Cord | 1 | 1994 | 85 | 0.010 |
Why?
| | Immunologic Techniques | 2 | 1983 | 40 | 0.010 |
Why?
| | Antibodies, Anti-Idiotypic | 2 | 1983 | 59 | 0.010 |
Why?
| | Pedigree | 1 | 1994 | 514 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1993 | 166 | 0.010 |
Why?
| | Neurons | 1 | 2002 | 1590 | 0.010 |
Why?
| | Microsomes | 1 | 1992 | 33 | 0.010 |
Why?
| | Genetic Variation | 2 | 1990 | 991 | 0.010 |
Why?
| | Zinc | 1 | 1995 | 297 | 0.010 |
Why?
| | Drug Synergism | 2 | 1983 | 382 | 0.010 |
Why?
| | Models, Structural | 1 | 1991 | 40 | 0.010 |
Why?
| | Methionine | 1 | 1992 | 160 | 0.010 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 21 | 0.010 |
Why?
| | Calcimycin | 1 | 1991 | 49 | 0.010 |
Why?
| | Carbohydrates | 1 | 1991 | 65 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 1997 | 927 | 0.010 |
Why?
| | Arthritis | 1 | 1991 | 96 | 0.010 |
Why?
| | Genes, MHC Class I | 1 | 1990 | 35 | 0.010 |
Why?
| | Cricetulus | 1 | 1989 | 109 | 0.000 |
Why?
| | Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.000 |
Why?
| | Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.000 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 15 | 0.000 |
Why?
| | Phosphorylcholine | 1 | 1988 | 20 | 0.000 |
Why?
| | Reference Values | 1 | 1990 | 816 | 0.000 |
Why?
| | Extracellular Space | 1 | 1989 | 119 | 0.000 |
Why?
| | Cross-Linking Reagents | 1 | 1989 | 217 | 0.000 |
Why?
| | Bacteriophage lambda | 1 | 1988 | 88 | 0.000 |
Why?
| | Mannose | 1 | 1987 | 24 | 0.000 |
Why?
| | Hexosaminidases | 1 | 1987 | 18 | 0.000 |
Why?
| | Introns | 1 | 1988 | 258 | 0.000 |
Why?
| | Exons | 1 | 1988 | 355 | 0.000 |
Why?
| | Oligosaccharides | 1 | 1987 | 60 | 0.000 |
Why?
| | Enhancer Elements, Genetic | 1 | 1988 | 190 | 0.000 |
Why?
| | Pepsin A | 1 | 1986 | 19 | 0.000 |
Why?
| | Hypersensitivity, Delayed | 2 | 1978 | 28 | 0.000 |
Why?
| | Vinblastine | 2 | 1976 | 71 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1990 | 400 | 0.000 |
Why?
| | Immunoglobulin J-Chains | 1 | 1985 | 6 | 0.000 |
Why?
| | Immunoenzyme Techniques | 1 | 1985 | 219 | 0.000 |
Why?
| | Genetic Code | 1 | 1985 | 22 | 0.000 |
Why?
| | Protein Denaturation | 1 | 1984 | 74 | 0.000 |
Why?
| | Immunoglobulin Light Chains | 1 | 1984 | 47 | 0.000 |
Why?
| | Membranes, Artificial | 1 | 1984 | 72 | 0.000 |
Why?
| | Albumins | 1 | 1984 | 114 | 0.000 |
Why?
| | Thymus Neoplasms | 1 | 1984 | 25 | 0.000 |
Why?
| | Bacteria | 1 | 1991 | 858 | 0.000 |
Why?
| | Macrophage-Activating Factors | 1 | 1983 | 4 | 0.000 |
Why?
| | Fixatives | 1 | 1983 | 15 | 0.000 |
Why?
| | Glutaral | 1 | 1983 | 16 | 0.000 |
Why?
| | Cell-Free System | 1 | 1983 | 53 | 0.000 |
Why?
| | Receptors, Antigen | 1 | 1983 | 16 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1990 | 2860 | 0.000 |
Why?
| | Cell Nucleus | 1 | 1985 | 620 | 0.000 |
Why?
| | Fetal Blood | 1 | 1983 | 327 | 0.000 |
Why?
| | Pulmonary Alveoli | 1 | 1983 | 405 | 0.000 |
Why?
| | Polymers | 1 | 1983 | 490 | 0.000 |
Why?
| | Isoantigens | 1 | 1977 | 15 | 0.000 |
Why?
| | Skin Tests | 1 | 1975 | 101 | 0.000 |
Why?
| | Child | 1 | 1994 | 21989 | 0.000 |
Why?
| | Immunoglobulin M | 1 | 1975 | 289 | 0.000 |
Why?
|
|
Marrack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|